Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and valsartan

angiotensin ii, des-phe(8)- has been researched along with valsartan in 7 studies

Compound Research Comparison

Studies
(angiotensin ii, des-phe(8)-)
Trials
(angiotensin ii, des-phe(8)-)
Recent Studies (post-2010)
(angiotensin ii, des-phe(8)-)
Studies
(valsartan)
Trials
(valsartan)
Recent Studies (post-2010) (valsartan)
1,533219953,5778712,140

Protein Interaction Comparison

ProteinTaxonomyangiotensin ii, des-phe(8)- (IC50)valsartan (IC50)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0027
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0023
Type-1 angiotensin II receptorHomo sapiens (human)0.0074

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chappell, MC; Ferrario, CM; Gallagher, PE; Tallant, EA1
Lin, CS; Pan, CH; Wen, CH1
Hirooka, Y; Hoka, S; Ito, K; Kishi, T; Nakagaki, T; Sunagawa, K1
Durik, M; Roks, AJ; Sevá Pessôa, B1
An, Y; Li, YH; Liu, P; Man, YL; Ren, BB; Wang, QX1
Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y1
Deng, CY; Guo, HM; Li, X; Liu, FZ; Liu, Y; Rao, F; Wang, ZY; Wei, W; Wu, SL; Xue, YM; Yang, H; Zhang, MZ1

Reviews

1 review(s) available for angiotensin ii, des-phe(8)- and valsartan

ArticleYear
The renin-angiotensin system, bone marrow and progenitor cells.
    Clinical science (London, England : 1979), 2012, Aug-01, Volume: 123, Issue:4

    Topics: Adipogenesis; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Marrow; Erythropoiesis; Hematopoiesis; Humans; Kidney; Mesenchymal Stem Cells; Metabolic Syndrome; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stem Cells; Tetrazoles; Valine; Valsartan

2012

Other Studies

6 other study(ies) available for angiotensin ii, des-phe(8)- and valsartan

ArticleYear
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
    American journal of physiology. Cell physiology, 2006, Volume: 290, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Astrocytes; Carboxypeptidases; Cells, Cultured; Cerebellum; Female; Gene Expression Regulation; Imidazoles; Losartan; Medulla Oblongata; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents

2006
Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Experimental physiology, 2008, Volume: 93, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Cells, Cultured; DNA; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Indicators and Reagents; Matrix Metalloproteinases; Myocytes, Cardiac; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazoles; Tissue Inhibitor of Metalloproteinases; Transcription, Genetic; Valine; Valsartan

2008
Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Tetrazoles; Valine; Valsartan

2011
[Effects of valsartan on aortic angiotensin converting enzyme 2 expression after aortic balloon injury in rats].
    Zhonghua xin xue guan bing za zhi, 2012, Volume: 40, Issue:8

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Intra-Aortic Balloon Pumping; Male; Muscle, Smooth, Vascular; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan

2012
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.
    Kidney international, 2015, Volume: 87, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A

2015
High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
    Journal of molecular and cellular cardiology, 2020, Volume: 140

    Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Hydrostatic Pressure; Mice; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; src-Family Kinases; Up-Regulation; Valsartan

2020